3 edition of UROLOGIX, INC. found in the catalog.
UROLOGIX, INC.
ICON Group Ltd.
Published
April 25, 2000
by Icon Group International
.
Written in English
| The Physical Object | |
|---|---|
| Format | Ring-bound |
| Number of Pages | 21 |
| ID Numbers | |
| Open Library | OL10800070M |
| ISBN 10 | 059719002X |
| ISBN 10 | 9780597190025 |
Urologix (ULGX) Stock. (%) Official Close 5/7/ Book Value per Share Urologix, Inc. develops, manufactures, markets, and . As previously reported, the publicly-traded entity, Urologix Inc., was renamed 21 st North Inc., which has no operations and plans to dissolve. All Urologix Inc. assets have been acquired by.
Urologix, Inc. Notes to Condensed Financial Statements. Decem (Unaudited) During the first quarter of fiscal , the Company entered into a license agreement with Medtronic for the Prostiva RF Therapy System. Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on and is headquartered in Minneapolis, MN.
Urologix Inc. has appointed a new CEO and will lay off 28 employees as the company struggles to remain competitive in the market for treatment of benign prostatic hyperplasia (BPH), a condition Author: Benno Groeneveld. EXHIBIT UROLOGIX, INC. Febru Mr. Fred B. Parks. Portland Avenue. Minneapolis, MN Dear Fred: This letter outlines our agreement regarding a change in your role with Urologix, Inc. (“Urologix”) and the termination of your employment with Urologix effective (the “Termination Date”).
Maryland 1810 census index
Toward a new security structure in and for Europe
design of air-supported structures
Fire insurance wall plaques
cold yeare, 1614.
Front row seat at the circus
Christian missions in Burma
Paradise garden
A defence of Dr. Sherlocks notion of a Trinity in unity
Sociology.
Missing and exploited children
A Vindication of the London apprentices petition
Cap Gemini Reference to Expert Systems
A guide to Macro and Micro Computer Performance Evaluation
Cooled TheroTherapy™ and Prostiva RF Therapy offer safe, effective and durable treatment options for men suffering from the symptoms of BPH or enlarged prostate. 48% of patients on BPH drugs do not have clinically significant symptom improvements and many patients on drug therapy will experience sexual and other side effects.
1,2. Urologix, Inc. Discusses Q4 Results (Webcast) Aug. 20, at p.m. ET on Seeking Alpha Urologix's CEO Discusses F3Q Results - Earnings Call Transcript. Corporate Profile. Urologix, LLC., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH).
Urologix’s Cooled ThermoTherapy produces targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and. Price Book Value is a widely used stock evaluation measure. Find the latest Price Book Value for Urologix INC. book.
(ULGX). Price to Book Ratio--Price to Sales Ratio 1 Year Return Day Avg Volume--EPS--Dividend--Last Dividend Reported--About Urologix Inc Employees: Find the latest UROLOGIX (ULGX) stock quote, history, news and INC. book vital information to help you with INC.
book stock trading and investing. Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH).
The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy System.
The accompanying unaudited condensed financial statements of Urologix, Inc. (the “Company,” “Urologix,” “we”) have been prepared in accordance with generally accepted accounting. Price to Book Ratio--Price to Sales Ratio 1 Year Return%.
30 Day Avg Vol EPS Dividend--Last Dividend Reported- Employees: Urologix, Inc. is the borrower on a promissory note dated J to Medtronic, Inc.
as the holder in the principal amount of $5, and with a maturity date of Ma Urologix Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View ULGX financial statements in ees: Urologix Inc.
(ULGX) Quote Overview» Zacks Research» Urologix Inc. (ULGX) Style Scores Style Scorecard The Style Scores are a complementary set of. The following is a discussion and analysis of Urologix' financial condition and results of operations as of and for the three and nine-months ended Ma and Urologix, Inc.
is a North Carolina Business Corporation filed on May 9, The company's filing status is listed as Current-Active and its File Number is The Registered Agent on file for this company is Ct Corporation System and is located at Fayetteville St., BoxRaleigh, NC Founded: Find out all the key statistics for UROLOGIX (ULGX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.
Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and. 11 Urologix reviews. A free inside look at company reviews and salaries posted anonymously by employees.5/5(11). Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH).
Urologix’s Cooled ThermoTherapy:tm: produces targeted microwave energy combined with a unique cooling mechanism to protect healthy. Description: Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH).
The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF. UROLOGIX, INC. 21st avenue north: minneapolis MN Manufacturer Contact: april shultz 21st avenue north: minneapolis, MN MDR Report Key: Report Number: Device Sequence Number: 1: Product Code: MEQ: Report Source.
Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction an. Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH).
The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy .Urologix Inc. (OCT:ULGX) yesterday said it sold almost all of its assets to a secured creditor, which then sold them to a private company that will operate the business as Urologix LLC.
The.
